<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Excitatory amino acids (EAAs) play an important role during ischemic brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>In this study we examined the protective effect of histogranin (HN), an endogenous <z:chebi fb="7" ids="16670">peptide</z:chebi> that antagonizes excitatory amino acids-mediated activity noncompetitively, in an animal model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Adult rats were anesthetized with chloral <z:chebi fb="1" ids="35505">hydrate</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Histogranin was given intracerebroventricularly before a 60-min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) </plain></SENT>
<SENT sid="4" pm="."><plain>Animals were examined for their locomotor activity 2 days after MCAo </plain></SENT>
<SENT sid="5" pm="."><plain>Histogranin significantly <z:mp ids='MP_0001399'>increased locomotor activity</z:mp> in the <z:hpo ids='HP_0001297'>stroke</z:hpo> rats </plain></SENT>
<SENT sid="6" pm="."><plain>Histogranin pretreatment reduced the volume of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and the caspase-3 immunoreactivity in the <z:hpo ids='HP_0001297'>stroke</z:hpo> animals </plain></SENT>
<SENT sid="7" pm="."><plain>Taken together, our data suggest that histogranin is protective against ischemic brain injury </plain></SENT>
<SENT sid="8" pm="."><plain>The protective effect may involve anti-apoptotic mechanisms </plain></SENT>
</text></document>